Christian Hopfer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Christian Hopfer has a total of 478 co-authors. Here are the top co-authors by number of shared publications:
- John K. Hewitt
Institute for Behavioral Genetics, University of Colorado Boulder
6 shared publications - Michael C. Stallings
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, USA
6 shared publications - Sandra A. Brown
University of California San Diego
6 shared publications - Jarrod M. Ellingson
Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, USA
5 shared publications - Robin P. Corley
Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA
5 shared publications - Tamara L. Wall
University of California, San Diego
4 shared publications
Latest Publications
- 28 October 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 158
The effects of cannabis legalization on psychological and physical impairment in individuals who use cannabis frequently
- 28 October 2026
- Published by Elsevier in International Journal of Drug Policy
- Vol. 158
The effects of cannabis legalization on psychological and physical impairment in individuals who use cannabis frequently
- Open Access
- 24 February 2026
- Published by Center for Open Science in PsyArXiv
A longitudinal, sibling-comparison study of trauma exposure during adolescence and trajectories of externalizing problems through young adulthood.
Childhood maltreatment has been implicated in adulthood externalizing behaviors. However, this relationship could be explained by confounding factors (e.g., externalizing risk factors that co-occur with childhood maltreatment), rather than a direct effect of maltreatment on externalizing behavior. The current study extends this research using a longitudinal sibling study. Specifically, we leveraged the sibling-comparison design, which compares siblings from the same family to each other to examine whether greater maltreatment exposure at baseline (M age = 16.9) is associated with greater increases in externalizing behavior through young adulthood (M age = 29.1). Thus, this approach controls for familial risk factors shared by siblings. Participants included 365 probands and 376 siblings who were followed across three assessment waves. Participants were administered clinical interviews at each wave to assess alcohol use disorder (AUD), illicit substance use disorder (SUD), and antisocial behavior (ASB), and a self-report survey of exposure to physical abuse, emotional abuse, sexual abuse, and neglect. Greater adolescent exposure to neglect and physical abuse were both associated with greater adolescent levels of AUD and ASB. Adolescent physical abuse, but not neglect, was also associated with greater illicit SUD symptoms. Additionally, greater emotional abuse was associated with steeper increases in AUD and illicit SUD symptoms through young adulthood. Importantly, none of these effects were explained by familial confounds. These findings provide strong evidence for adolescent emotional abuse playing a causal role in later AUD/SUD, suggesting that preventing such abuse and mitigating its effects may have downstream effects on reducing AUD/SUD.
- 24 February 2026
- Published by Center for Open Science in PsyArXiv
Open AccessA longitudinal, sibling-comparison study of trauma exposure during adolescence and trajectories of externalizing problems through young adulthood.
Childhood maltreatment has been implicated in adulthood externalizing behaviors. However, this relationship could be explained by confounding factors (e.g., externalizing risk factors that co-occur with childhood maltreatment), rather than a direct effect of maltreatment on externalizing behavior. The current study extends this research using a longitudinal sibling study. Specifically, we leveraged the sibling-comparison design, which compares siblings from the same family to each other to examine whether greater maltreatment exposure at baseline (M age = 16.9) is associated with greater increases in externalizing behavior through young adulthood (M age = 29.1). Thus, this approach controls for familial risk factors shared by siblings. Participants included 365 probands and 376 siblings who were followed across three assessment waves. Participants were administered clinical interviews at each wave to assess alcohol use disorder (AUD), illicit substance use disorder (SUD), and antisocial behavior (ASB), and a self-report survey of exposure to physical abuse, emotional abuse, sexual abuse, and neglect. Greater adolescent exposure to neglect and physical abuse were both associated with greater adolescent levels of AUD and ASB. Adolescent physical abuse, but not neglect, was also associated with greater illicit SUD symptoms. Additionally, greater emotional abuse was associated with steeper increases in AUD and illicit SUD symptoms through young adulthood. Importantly, none of these effects were explained by familial confounds. These findings provide strong evidence for adolescent emotional abuse playing a causal role in later AUD/SUD, suggesting that preventing such abuse and mitigating its effects may have downstream effects on reducing AUD/SUD.
- Open Access
- 2 January 2026
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 23, 100664
Etiology of longitudinal associations between subjective effects and substance use disorders in a clinical sample
- 2 January 2026
- Published by Elsevier in Addictive Behaviors Reports
- Vol. 23, 100664
Open AccessEtiology of longitudinal associations between subjective effects and substance use disorders in a clinical sample
- 11 December 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 113001
Enhancing data compatibility in an evolving landscape: Medical cannabis and polysubstance use protocols in the PhenX Toolkit
- 11 December 2025
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 278, 113001
Enhancing data compatibility in an evolving landscape: Medical cannabis and polysubstance use protocols in the PhenX Toolkit
- Open Access
- 23 November 2025
- Published by Center for Open Science in PsyArXiv
A longitudinal, sibling-comparison study of alcohol use disorder and co-occurring internalizing problems across adolescence and young adulthood
Background: Internalizing disorders frequently co-occur with alcohol use disorder (AUD) and impede alcohol recovery, but directionality among these disorders is unclear. Further, shared risk factors may explain the co-occurrence of these disorders, rather than either disorder directly affecting the other. Additionally, there is evidence that these disorders are differentially associated in men and women. Method: The current study examined a sample of clinical probands, recruited during adolescence based on externalizing problems, and their siblings to understand whether adolescent alcohol behavior is associated with changes in anxiety and depressive symptoms through young adulthood, and vice-versa. Participants were 1,161 individuals who completed a clinical interview in adolescence (M age=16.3) and at two subsequent waves (M age=22.6 and 28.5). Latent growth curve models tested whether baseline levels behavior (e.g., AUD) is associated with linear change in internalizing problems (e.g., depression) through young adulthood. Further, sibling-comparison analyses were conducted to control familial risk factors shared by siblings while testing whether siblings who have higher levels an independent variable (e.g., adolescent AUD) have proportionally greater increases in an outcome (e.g., depression), relative to their siblings with lower levels of that independent variable. Results: Adolescent AUD was associated with steeper increases in major depressive symptoms through young adulthood, and these effects were not explained by familial confounds. Additionally, adolescent AUD was associated with more adolescent generalized anxiety symptoms in females but less generalized anxiety symptoms among males. Conclusions: These findings suggest that treating early-life AUD may decrease risk for depressive symptoms later in life, but the inverse may not be true.
- 23 November 2025
- Published by Center for Open Science in PsyArXiv
Open AccessA longitudinal, sibling-comparison study of alcohol use disorder and co-occurring internalizing problems across adolescence and young adulthood
Background: Internalizing disorders frequently co-occur with alcohol use disorder (AUD) and impede alcohol recovery, but directionality among these disorders is unclear. Further, shared risk factors may explain the co-occurrence of these disorders, rather than either disorder directly affecting the other. Additionally, there is evidence that these disorders are differentially associated in men and women. Method: The current study examined a sample of clinical probands, recruited during adolescence based on externalizing problems, and their siblings to understand whether adolescent alcohol behavior is associated with changes in anxiety and depressive symptoms through young adulthood, and vice-versa. Participants were 1,161 individuals who completed a clinical interview in adolescence (M age=16.3) and at two subsequent waves (M age=22.6 and 28.5). Latent growth curve models tested whether baseline levels behavior (e.g., AUD) is associated with linear change in internalizing problems (e.g., depression) through young adulthood. Further, sibling-comparison analyses were conducted to control familial risk factors shared by siblings while testing whether siblings who have higher levels an independent variable (e.g., adolescent AUD) have proportionally greater increases in an outcome (e.g., depression), relative to their siblings with lower levels of that independent variable. Results: Adolescent AUD was associated with steeper increases in major depressive symptoms through young adulthood, and these effects were not explained by familial confounds. Additionally, adolescent AUD was associated with more adolescent generalized anxiety symptoms in females but less generalized anxiety symptoms among males. Conclusions: These findings suggest that treating early-life AUD may decrease risk for depressive symptoms later in life, but the inverse may not be true.
- Open Access
- 22 September 2025
- Published by Center for Open Science in PsyArXiv
Cannabis use and suicidal thoughts and behavior: A multi-site, co-twin control study from adolescence through middle adulthood
Background: Observational studies have repeatedly linked cannabis use to increased suicidality, yet cannabis use rarely exists in isolation from other risk factors. We therefore tested whether these associations reflect a causal effect, reverse causation, or residual confounding.Methods: We analyzed twin cohorts based in Colorado and Minnesota (N = 6,420) followed from late adolescence into middle adulthood, with repeated assessments of cannabis use and suicidal thoughts/behavior (STB). Prospective and co-twin control analyses examined (a) cross-sectional and prospective links between cannabis use and STB, (b) whether these links persisted after adjusting for genetic and environmental confounds, and (c) whether middle-adulthood associations were moderated by legalized recreational cannabis.Findings: More frequent cannabis use was associated with elevated STB. After accounting for shared familial factors via co-twin control, this relationship remained significant in cross-sectional, but not prospective, analyses. In middle adulthood, associations between cannabis use and STB did not differ across states, regardless of recreational cannabis legalization status. Interpretation: Findings support a contemporaneous link between cannabis use and STB within twin pairs, potentially reflecting causal effects. However, the absence of a prospective within-pair association provides little support for the notion that cannabis use elevates future STB risk independent of familial liability. This pattern suggests causation may be limited to short-term effects, or that the cannabis-STB relationship may primarily reflect confounding by unmeasured time-varying factors (e.g., acute stressors).
- 22 September 2025
- Published by Center for Open Science in PsyArXiv
Open AccessCannabis use and suicidal thoughts and behavior: A multi-site, co-twin control study from adolescence through middle adulthood
Background: Observational studies have repeatedly linked cannabis use to increased suicidality, yet cannabis use rarely exists in isolation from other risk factors. We therefore tested whether these associations reflect a causal effect, reverse causation, or residual confounding.Methods: We analyzed twin cohorts based in Colorado and Minnesota (N = 6,420) followed from late adolescence into middle adulthood, with repeated assessments of cannabis use and suicidal thoughts/behavior (STB). Prospective and co-twin control analyses examined (a) cross-sectional and prospective links between cannabis use and STB, (b) whether these links persisted after adjusting for genetic and environmental confounds, and (c) whether middle-adulthood associations were moderated by legalized recreational cannabis.Findings: More frequent cannabis use was associated with elevated STB. After accounting for shared familial factors via co-twin control, this relationship remained significant in cross-sectional, but not prospective, analyses. In middle adulthood, associations between cannabis use and STB did not differ across states, regardless of recreational cannabis legalization status. Interpretation: Findings support a contemporaneous link between cannabis use and STB within twin pairs, potentially reflecting causal effects. However, the absence of a prospective within-pair association provides little support for the notion that cannabis use elevates future STB risk independent of familial liability. This pattern suggests causation may be limited to short-term effects, or that the cannabis-STB relationship may primarily reflect confounding by unmeasured time-varying factors (e.g., acute stressors).
- Open Access
- 29 August 2023
- Published by Center for Open Science in PsyArXiv
The Dark Sides of the Brain: A Systematic Review and Meta-Analysis of Functional Neuroimaging Studies on Aggression
Background. Aggression is a worldwide issue that has significant consequences for both the victims and societies. However, aggression is an umbrella terms with subcomponents such as motivation (i.e., Reactive versus Proactive) and forms (i.e., Physical versus Verbal) which aggressive behaviors may occur. Yet, brain circuits differentiating these subcomponents remains largely unknown.Method. A systematic search strategy was conducted up to May 1st 2023, using PubMed, Google Scholar, and Web of Science, to identify relevant studies. Coordinate-based meta-analysis was conducted on General Aggression, Reactive Aggression, Proactive Aggression, Physical Aggression and Verbal Aggression using spatial convergence (ALE) and effect-size (SDM-PSI) approaches.Results. Sixty-seven studies met the inclusion criteria. Meta-analysis revealed similar yet distinct neural correlates for General Aggression (i.e., Amygdala, Precuneus, Intraparietal Sulcus, Angular and Middle Temporal Gyri), Reactive Aggression (i.e., Amygdala, Periaqueductal Grey, Posterior Insula, & Central Opercular Cortex), Proactive Aggression (i.e., Septal Area, & Amygdala), Physical Aggression (i.e., Dorsal Premotor Cortex, Dorsal Caudate, & Dorsal Anterior Cingulate Cortex), and Verbal (i.e., Dorsal Anterior Cingulate Cortex). Exploratory analyses revealed the importance of affective, cognitive and social cognition processes as well as serotoninergic, dopaminergic, and cholinergic systems in the neural underpinnings of aggressive behaviors.Conclusion. Our findings highlight the importance of examining the subcomponents of aggression (i.e., motivation and forms) within a transdiagnostic framework. Hence, characterizing the neurobiological substrates of aggression may expand our search for targeted neuromodulation and pharmacological treatments.
- 29 August 2023
- Published by Center for Open Science in PsyArXiv
Open AccessThe Dark Sides of the Brain: A Systematic Review and Meta-Analysis of Functional Neuroimaging Studies on Aggression
Background. Aggression is a worldwide issue that has significant consequences for both the victims and societies. However, aggression is an umbrella terms with subcomponents such as motivation (i.e., Reactive versus Proactive) and forms (i.e., Physical versus Verbal) which aggressive behaviors may occur. Yet, brain circuits differentiating these subcomponents remains largely unknown.Method. A systematic search strategy was conducted up to May 1st 2023, using PubMed, Google Scholar, and Web of Science, to identify relevant studies. Coordinate-based meta-analysis was conducted on General Aggression, Reactive Aggression, Proactive Aggression, Physical Aggression and Verbal Aggression using spatial convergence (ALE) and effect-size (SDM-PSI) approaches.Results. Sixty-seven studies met the inclusion criteria. Meta-analysis revealed similar yet distinct neural correlates for General Aggression (i.e., Amygdala, Precuneus, Intraparietal Sulcus, Angular and Middle Temporal Gyri), Reactive Aggression (i.e., Amygdala, Periaqueductal Grey, Posterior Insula, & Central Opercular Cortex), Proactive Aggression (i.e., Septal Area, & Amygdala), Physical Aggression (i.e., Dorsal Premotor Cortex, Dorsal Caudate, & Dorsal Anterior Cingulate Cortex), and Verbal (i.e., Dorsal Anterior Cingulate Cortex). Exploratory analyses revealed the importance of affective, cognitive and social cognition processes as well as serotoninergic, dopaminergic, and cholinergic systems in the neural underpinnings of aggressive behaviors.Conclusion. Our findings highlight the importance of examining the subcomponents of aggression (i.e., motivation and forms) within a transdiagnostic framework. Hence, characterizing the neurobiological substrates of aggression may expand our search for targeted neuromodulation and pharmacological treatments.
- 15 April 2022
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 33 (3) , 637-650
The impact of recreational cannabis legalization on youth: the Colorado experience
Over the past two decades, cannabis policies have liberalized in the United States, culminating in the legalization of recreational cannabis in Colorado and Washington state in 2012. This review will focus on the impact of recreational cannabis legalization in Colorado. While the prevalence of past-year and past-month cannabis use has remained relatively steady among adolescents post-legalization, the prevalence of young adult use has continued to rise. Cannabis products with increased potency have become more prevalent and widely used. There are concerns that the use of products with increased potency will increase risk for cannabis use and comorbid mental health disorders, particularly cannabis-induced psychosis and suicidal behavior, although more research is needed to fully understand the impact of high-potency products. Since the legalization of recreational cannabis, numerous additional public health concerns have emerged: unintentional overdoses requiring acute care visits, electronic vaping-associated lung injury, increased motor vehicle collisions related to cannabis consumption, and higher rates of cannabis use during pregnancy. Lessons learned from the first decade of cannabis legalization emphasize the need for research efforts to provide evidence-based guidelines, inform prevention strategies, and implement selective interventions for at-risk populations including youth, individuals with comorbid mental health disorders, and individuals who are pregnant.
- 15 April 2022
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 33 (3) , 637-650
The impact of recreational cannabis legalization on youth: the Colorado experience
Over the past two decades, cannabis policies have liberalized in the United States, culminating in the legalization of recreational cannabis in Colorado and Washington state in 2012. This review will focus on the impact of recreational cannabis legalization in Colorado. While the prevalence of past-year and past-month cannabis use has remained relatively steady among adolescents post-legalization, the prevalence of young adult use has continued to rise. Cannabis products with increased potency have become more prevalent and widely used. There are concerns that the use of products with increased potency will increase risk for cannabis use and comorbid mental health disorders, particularly cannabis-induced psychosis and suicidal behavior, although more research is needed to fully understand the impact of high-potency products. Since the legalization of recreational cannabis, numerous additional public health concerns have emerged: unintentional overdoses requiring acute care visits, electronic vaping-associated lung injury, increased motor vehicle collisions related to cannabis consumption, and higher rates of cannabis use during pregnancy. Lessons learned from the first decade of cannabis legalization emphasize the need for research efforts to provide evidence-based guidelines, inform prevention strategies, and implement selective interventions for at-risk populations including youth, individuals with comorbid mental health disorders, and individuals who are pregnant.
- Open Access
- 31 March 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (7) , 934-945
Genome-wide Association Meta-analysis of Childhood and Adolescent Internalizing Symptoms
- 31 March 2022
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (7) , 934-945
Open AccessGenome-wide Association Meta-analysis of Childhood and Adolescent Internalizing Symptoms
- 1 February 2022
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 7 (1) , 65-77
An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses
Introduction: Relatively little is known about the molecular pathways influenced by cannabis use in humans. We used a multi-omics approach to examine protein, metabolomic, and lipid markers in plasma differentiating between cannabis users and nonusers to understand markers associated with cannabis use. Methods: Eight discordant twin pairs and four concordant twin pairs for cannabis use completed a blood draw, urine and plasma toxicology testing, and provided information about their past 30-day cannabis use and other substance use patterns. The 24 twins were all non-Hispanic whites. Sixty-six percent were female. Median age was 30 years. Fifteen participants reported that they had used cannabis in the last 30 days, including eight participants that used every day or almost every day (29–30 of 30 days). Of these 15 participants, plasma 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol (THC-COOH) and total tetrahydrocannabinol (THC) concentrations were detectable in 12 participants. Among the eight “heavy users” the amount of total THC (sum of THC and its metabolites) and plasma THC-COOH concentrations varied widely, with ranges of 13.1–1713 ng/mL and 2.7–284 ng/mL, respectively. A validated liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay measured plasma THC-COOH, THC, and other cannabinoids and metabolites. Plasma THC-COOH was used as the primary measure. Expression levels of 1305 proteins were measured using SOMAScan assay, and 34 lipid mediators and 314 metabolites were measured with LC-MS/MS. Analyses examined associations between markers and THC-COOH levels with and without taking genetic relatedness into account. Results: Thirteen proteins, three metabolites, and two lipids were identified as associated with THC-COOH levels. Myc proto-oncogene was identified as associated with THC-COOH levels in both molecular insight and potential marker analyses. Five pathways (interleukin-6 production, T lymphocyte regulation, apoptosis, kinase signaling pathways, and nuclear factor kappa-light-chain-enhancer of activated B cells) were linked with molecules identified in these analyses. Conclusions: THC-COOH levels are associated with immune system-related pathways. This study presents a feasible approach to identify additional molecular markers associated with THC-COOH levels.
- 1 February 2022
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 7 (1) , 65-77
An Approach to Biomarker Discovery of Cannabis Use Utilizing Proteomic, Metabolomic, and Lipidomic Analyses
Introduction: Relatively little is known about the molecular pathways influenced by cannabis use in humans. We used a multi-omics approach to examine protein, metabolomic, and lipid markers in plasma differentiating between cannabis users and nonusers to understand markers associated with cannabis use. Methods: Eight discordant twin pairs and four concordant twin pairs for cannabis use completed a blood draw, urine and plasma toxicology testing, and provided information about their past 30-day cannabis use and other substance use patterns. The 24 twins were all non-Hispanic whites. Sixty-six percent were female. Median age was 30 years. Fifteen participants reported that they had used cannabis in the last 30 days, including eight participants that used every day or almost every day (29–30 of 30 days). Of these 15 participants, plasma 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol (THC-COOH) and total tetrahydrocannabinol (THC) concentrations were detectable in 12 participants. Among the eight “heavy users” the amount of total THC (sum of THC and its metabolites) and plasma THC-COOH concentrations varied widely, with ranges of 13.1–1713 ng/mL and 2.7–284 ng/mL, respectively. A validated liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay measured plasma THC-COOH, THC, and other cannabinoids and metabolites. Plasma THC-COOH was used as the primary measure. Expression levels of 1305 proteins were measured using SOMAScan assay, and 34 lipid mediators and 314 metabolites were measured with LC-MS/MS. Analyses examined associations between markers and THC-COOH levels with and without taking genetic relatedness into account. Results: Thirteen proteins, three metabolites, and two lipids were identified as associated with THC-COOH levels. Myc proto-oncogene was identified as associated with THC-COOH levels in both molecular insight and potential marker analyses. Five pathways (interleukin-6 production, T lymphocyte regulation, apoptosis, kinase signaling pathways, and nuclear factor kappa-light-chain-enhancer of activated B cells) were linked with molecules identified in these analyses. Conclusions: THC-COOH levels are associated with immune system-related pathways. This study presents a feasible approach to identify additional molecular markers associated with THC-COOH levels.